Simcere Pharmaceutical Group. (NYSE:SCR) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Simcere Pharmaceutical Group. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 125% to $0.09 in the quarter versus EPS of $0.04 in the year-earlier quarter.
Revenue: Rose 9.88% to $85.1 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Simcere Pharmaceutical Group. reported adjusted EPS income of $0.09 per share. By that measure, the company beat the mean analyst estimate of $0.08. It beat the average revenue estimate of $82.84 million.
Quoting Management: Mr. Hongquan Liu, Executive Director and Chief Executive Officer of Simcere Pharmaceutical Group, commented, “We experienced moderate sales growth in the first quarter despite sustained pricing restrictions from the government and intensifying competition. I am pleased that our overall business performance improved during the quarter and that both Sales and Marketing expenses and General and Administrative expenses as percentages of our total revenue decreased slightly.”
Key Stats (on next page)…
Revenue decreased 4.7% from $89.3 million in the previous quarter. EPS decreased 62.5% from $0.24 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.11 to a profit $0.12. For the current year, the average estimate has moved up from a profit of $0.35 to a profit of $0.39 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)